FARLETUZUMAB

Welcome to the Brand page for “FARLETUZUMAB”, which is offered here for Therapeutic antibody for use in treating cancer;.

Its status is currently believed to be active. Its class is unavailable. “FARLETUZUMAB” is believed to be currently owned by “Morphotek, Inc.”


Owner:
MORPHOTEK, INC.
Owner Details
Description:
Therapeutic antibody for use in treating cancer;
Categories: THERAPEUTIC ANTIBODY USE